263 related articles for article (PubMed ID: 34950143)
1. Donor T-Cell Repertoire Profiling in Recipient Lymphoid and Parenchyma Organs Reveals GVHD Pathogenesis at Clonal Levels After Bone Marrow Transplantation in Mice.
Wu Y; Fu J; Wang H; Yu XZ
Front Immunol; 2021; 12():778996. PubMed ID: 34950143
[TBL] [Abstract][Full Text] [Related]
2. T Cell Repertoire Evolution after Allogeneic Bone Marrow Transplantation: An Organizational Perspective.
Meier JA; Haque M; Fawaz M; Abdeen H; Coffey D; Towlerton A; Abdeen A; Toor A; Warren E; Reed J; Kanakry CG; Keating A; Luznik L; Toor AA
Biol Blood Marrow Transplant; 2019 May; 25(5):868-882. PubMed ID: 30677510
[TBL] [Abstract][Full Text] [Related]
3. Endogenous superantigens in allogeneic bone marrow transplant recipients rapidly and selectively expand donor T cells which can produce IFN-gamma.
Jones MS; Riley R; Hamilton BL; Paupe J; Perez D; Levy RB
Bone Marrow Transplant; 1994 Nov; 14(5):725-35. PubMed ID: 7889005
[TBL] [Abstract][Full Text] [Related]
4. Secondary lymphoid organs contribute to, but are not required for the induction of graft-versus-host responses following allogeneic bone marrow transplantation: a shifting paradigm for T cell allo-activation.
Silva IA; Olkiewicz K; Askew D; Fisher JM; Chaudhary MN; Vannella KM; Deurloo DT; Choi SW; Pierce EM; Clouthier SG; Liu C; Cooke KR
Biol Blood Marrow Transplant; 2010 May; 16(5):598-611. PubMed ID: 20117226
[TBL] [Abstract][Full Text] [Related]
5. Recipient-specific T-cell repertoire reconstitution in the gut following murine hematopoietic cell transplant.
Zheng P; Tamaresis J; Thangavelu G; Xu L; You X; Blazar BR; Negrin RS; Zehnder JL; Iliopoulou BP; Meyer EH
Blood Adv; 2020 Sep; 4(17):4232-4243. PubMed ID: 32898248
[TBL] [Abstract][Full Text] [Related]
6. Ceacam1 separates graft-versus-host-disease from graft-versus-tumor activity after experimental allogeneic bone marrow transplantation.
Lu SX; Kappel LW; Charbonneau-Allard AM; Atallah R; Holland AM; Turbide C; Hubbard VM; Rotolo JA; Smith M; Suh D; King C; Rao UK; Yim N; Bautista JL; Jenq RR; Penack O; Na IK; Liu C; Murphy G; Alpdogan O; Blumberg RS; Macian F; Holmes KV; Beauchemin N; van den Brink MR
PLoS One; 2011; 6(7):e21611. PubMed ID: 21760897
[TBL] [Abstract][Full Text] [Related]
7. Changes in the T-cell receptor V beta gene repertoire after allogeneic hematopoietic stem cell transplantation.
Liu QF; Li YQ; Yang D; Zhang Y; Yang LJ; Chen SH; Sun J; Liu XL; Zhou SY
Chin Med J (Engl); 2004 Mar; 117(3):413-8. PubMed ID: 15043783
[TBL] [Abstract][Full Text] [Related]
8. Organ-specific T cell receptor repertoire in target organs of murine graft-versus-host after transplantation across minor histocompatibility antigen barriers.
Schilbach K; Schick J; Fluhr H; Marquordt K; Wehrmann M; Schütt BS; Schlegel PG; Niethammer D; Eyrich M
Transplantation; 2004 Jul; 78(1):31-40. PubMed ID: 15257036
[TBL] [Abstract][Full Text] [Related]
9. Distinct TCRAV and TCRBV repertoire and CDR3 sequence of T lymphocytes clonally expanded in blood and GVHD lesions after human allogeneic bone marrow transplantation.
Hirokawa M; Matsutani T; Saitoh H; Ichikawa Y; Kawabata Y; Horiuchi T; Kitabayashi A; Yoshioka T; Tsuruta Y; Suzuki R; Miura AB; Sawada K
Bone Marrow Transplant; 2002 Dec; 30(12):915-23. PubMed ID: 12476285
[TBL] [Abstract][Full Text] [Related]
10. Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution.
Gendelman M; Yassai M; Tivol E; Krueger A; Gorski J; Drobyski WR
Biol Blood Marrow Transplant; 2003 Dec; 9(12):742-52. PubMed ID: 14677113
[TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of T-cell receptor repertoire in bone marrow transplant recipients: evidence for oligoclonal T-cell expansion in graft-versus-host disease lesions.
Liu X; Chesnokova V; Forman SJ; Diamond DJ
Blood; 1996 Apr; 87(7):3032-44. PubMed ID: 8639927
[TBL] [Abstract][Full Text] [Related]
12. Host MyD88 signaling protects against acute graft-versus-host disease after allogeneic bone marrow transplantation.
Xing S; Zhang X; Liu JH; Huang X; Zhou P
Clin Exp Immunol; 2019 Jan; 195(1):121-131. PubMed ID: 30317551
[TBL] [Abstract][Full Text] [Related]
13. A radio-resistant perforin-expressing lymphoid population controls allogeneic T cell engraftment, activation, and onset of graft-versus-host disease in mice.
Davis JE; Harvey M; Gherardin NA; Koldej R; Huntington N; Neeson P; Trapani JA; Ritchie DS
Biol Blood Marrow Transplant; 2015 Feb; 21(2):242-9. PubMed ID: 25459639
[TBL] [Abstract][Full Text] [Related]
14. [Influence of mouse genetic engineering regulatory T cells infusion on post-allogeneic bone marrow transplantation acute graft-versus-host disease in mice].
Cao J; Li L; Chen C; Zeng LY; Li ZY; Pan XY; Xu KL
Zhonghua Xue Ye Xue Za Zhi; 2011 Feb; 32(2):83-8. PubMed ID: 21429372
[TBL] [Abstract][Full Text] [Related]
15. Severe graft-versus-host disease in SCID mice is associated with a decrease of selective donor cell TCR Vbeta specificities and increased expression of IFN-gamma and IL-4.
Schneider MK; Ekholm F; Grönvik KO
Scand J Immunol; 1997 Aug; 46(2):147-58. PubMed ID: 9583995
[TBL] [Abstract][Full Text] [Related]
16. Recipient-Derived Allo-iTregs Induced by Donor DCs Effectively Inhibit the Proliferation of Donor T Cells and Reduce GVHD.
Yang ZG; Wen RT; Feng JS; Cao PJ; Zhou HT; Liu WX
Anat Rec (Hoboken); 2019 May; 302(5):825-836. PubMed ID: 30312018
[TBL] [Abstract][Full Text] [Related]
17. Early changes in gene expression profiles of hepatic GVHD uncovered by oligonucleotide microarrays.
Ichiba T; Teshima T; Kuick R; Misek DE; Liu C; Takada Y; Maeda Y; Reddy P; Williams DL; Hanash SM; Ferrara JL
Blood; 2003 Jul; 102(2):763-71. PubMed ID: 12663442
[TBL] [Abstract][Full Text] [Related]
18. Tissue-specific homing and expansion of donor NK cells in allogeneic bone marrow transplantation.
Olson JA; Zeiser R; Beilhack A; Goldman JJ; Negrin RS
J Immunol; 2009 Sep; 183(5):3219-28. PubMed ID: 19657090
[TBL] [Abstract][Full Text] [Related]
19. The fate of donor T-cell receptor transgenic T cells with known host antigen specificity in a graft-versus-host disease model.
Dey B; Yang YG; Preffer F; Shimizu A; Swenson K; Dombkowski D; Sykes M
Transplantation; 1999 Jul; 68(1):141-9. PubMed ID: 10428282
[TBL] [Abstract][Full Text] [Related]
20. Treatment of donor mice with an alpha beta T-cell receptor monoclonal antibody induces prolonged T-cell nonresponsiveness and effectively prevents lethal graft-versus-host disease in murine recipients of major histocompatibility complex (MHC)-matched and MHC-mismatched donor marrow grafts.
Drobyski WR; Majewski D
Blood; 1996 Jun; 87(12):5355-69. PubMed ID: 8652851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
